Nuclear technique improves properties of innovative bone transplant material

ANSTO

Key Points

  • University of Sydney researchers and associates have developed an innovative bone implant that could reduce the bone implant failure rate to less than one per cent

  • The material, which uses the element gallium and an antimicrobial molecule defensin, significantly reduced infection and inflammation

  • The gallium was added to the implant using an ion implantation technique at ANSTO’s Centre for Accelerator Science.

A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.

The news has generated great interest because of the 1.7 million replacement procedures that are carried out in Australian each year. According to the Australian Orthopaedic Association as reported by the University of Sydney, approximately 20 per cent of implants will fail at 10 years.

Professor Wojciech Chrzanowski, from the University of Sydney Nano Institute and head of nanomedicine research at the Faculty of Medicine and Health led the international team which included ANSTO scientists.

This week they published a paper

/Public Release. View in full here.